Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 89.70
+3.35 (3.88%)
Jul 10, 2026, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 156.16 billion as of July 10, 2026. Its market cap has increased by 22.64% in one year.
Market Cap
156.16B
Enterprise Value
139.01B
Revenue
14.51B
Ranking
n/a
PE Ratio
171.50
Stock Price
89.70
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 156.16B, an increase of 742.34%. That is a compound annual growth rate of 31.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 156.16B | 18.07% |
| Dec 31, 2025 | 132.27B | 120.60% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.84B |
| WuXi Biologics | 152.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 110.76B |
| Akeso | 89.58B |
| Sino Biopharmaceutical | 89.15B |
| RemeGen | 70.89B |
| Biocytogen Pharmaceuticals (Beijing) | 46.49B |
| 3SBio | 42.51B |